Interaction Potential of Etravirine with Drug Transporters Assessed In Vitro

被引:29
|
作者
Zembruski, Nadine Cecile Luise [1 ]
Haefeli, Walter Emil [1 ]
Weiss, Johanna [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, D-69120 Heidelberg, Germany
关键词
MULTIDRUG-RESISTANCE PROTEIN-2; P-GLYCOPROTEIN; PROTEASE INHIBITORS; PHARMACOKINETICS; ATAZANAVIR; RITONAVIR; BLOCKERS; RECEPTOR; TMC125; CELLS;
D O I
10.1128/AAC.01527-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Etravirine is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV-1 infections. ABC transporters potentially mediate clinically relevant drug-drug interactions. We assessed substrate characteristics and the inhibitory and inductive potential of etravirine on ABC transporters. Etravirine did not inhibit P-gp/ABCB1 and was not transported by the tested ABC transporters but was a potent inhibitor of BCRP/ABCG2. Etravirine induced several ABC transporters, especially BCRP/ABCG2. These data demonstrate that etravirine has the potential for drug-drug interactions by modulation of expression and function of several ABC transporters.
引用
收藏
页码:1282 / 1284
页数:3
相关论文
共 50 条
  • [31] Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
    Weiss, Johanna
    Bajraktari-Sylejmani, Gzona
    Haefeli, Walter E.
    PHARMACEUTICS, 2020, 12 (10) : 1 - 13
  • [32] Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters
    Kunze, Annett
    Huwyler, Joerg
    Camenisch, Gian
    Gutmann, Heike
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (08) : 1096 - 1102
  • [33] Role of organic cation transporters in drug-drug interaction
    Koepsell, Hermann
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (10) : 1619 - 1633
  • [34] In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters
    Ramsden, Diane
    Wu, Jing-Tao
    Zerler, Brad
    Iqbal, Sajida
    Jiang, Jim
    Clausen, Valerie
    Aluri, Krishna
    Gu, Yongli
    Dennin, Sean
    Kim, Joohwan
    Chong, Saeho
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (10) : 1183 - 1194
  • [35] RITONAVIR INHIBITS PRASUGREL IN VITRO BIOACTIVATION: A POTENTIAL PHARMACOKINETIC DRUG-DRUG INTERACTION
    Ancrenaz, V.
    Daali, Y.
    Samer, C.
    Dayer, P.
    Desmeules, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S56 - S56
  • [36] In Vitro Investigations into the Potential Drug Interactions of Pseudoginsenoside DQ Mediated by Cytochrome P450 and Human Drug Transporters
    Li, Zhuo
    Wang, Cuizhu
    Liu, Jinping
    Li, Pingya
    Feng, Hao
    MOLECULES, 2024, 29 (11):
  • [37] In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
    Seo, Seong-Wook
    Park, Jin Woo
    Han, Dong-Gyun
    Kim, Ji-Min
    Kim, Sanghyun
    Park, Taeuk
    Kang, Kyung-Hwa
    Yang, Min Hye
    Yoon, In-Soo
    PHARMACEUTICS, 2019, 11 (12)
  • [38] In Vitro Evaluation of the Interaction Potential of Irosustat with Drug-Metabolizing Enzymes
    Ventura, Veronica
    Sola, Josep
    Peraire, Concepcion
    Bree, Francoise
    Obach, Rosendo
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (07) : 1268 - 1278
  • [39] A Comprehensive In Vivo and In Vitro Assessment of the Drug Interaction Potential of Red Ginseng
    Seong, Sook Jin
    Kang, Woo Youl
    Heo, Jae-Kyung
    Jo, Jungjae
    Choi, Won Gu
    Liu, Kwang-Hyeon
    Lee, Sangkyu
    Choi, Min-Koo
    Han, Yong-Hae
    Lee, Hye Suk
    Ohk, Boram
    Lee, Hae Won
    Song, Im-Sook
    Yoon, Young-Ran
    CLINICAL THERAPEUTICS, 2018, 40 (08) : 1322 - 1337
  • [40] Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia
    Alfedi, Giulia
    Luffarelli, Riccardo
    Condo, Ivano
    Pedini, Giorgia
    Mannucci, Liliana
    Massaro, Damiano S.
    Benini, Monica
    Toschi, Nicola
    Alaimo, Giorgia
    Panarello, Luca
    Pacini, Laura
    Fortuni, Silvia
    Serio, Dario
    Malisan, Florence
    Testi, Roberto
    Rufini, Alessandra
    MOVEMENT DISORDERS, 2019, 34 (03) : 323 - 334